Lista de obras -

A Canadian Cohort Study of Cognitive Impairment and Related Dementias (ACCORD): Study Methods and Baseline Results

article

Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods

article

Cardiovascular Outcomes in Action to Control Cardiovascular Risk in Diabetes: Impact of Blood Pressure Level and Presence of Kidney Disease

artículo científico publicado en 2016

Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes

artículo científico publicado en 2014

Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.

artículo científico publicado en 2011

Determinants of Weight Gain in the Action to Control Cardiovascular Risk in Diabetes Trial ⬇️

artículo científico publicado el 14 de febrero de 2013

Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial

artículo científico publicado en 2012

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study

artículo científico publicado en 2016

Effects of combination lipid therapy in type 2 diabetes mellitus

artículo científico publicado en 2010

Effects of intensive blood-pressure control in type 2 diabetes mellitus

artículo científico publicado en 2010

Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial

artículo científico publicado en 2014

Effects of medical therapies on retinopathy progression in type 2 diabetes

artículo científico publicado en 2010

Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

artículo científico publicado en 2007

Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

artículo científico publicado en 2007

Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design

artículo científico publicado en 2007

Lack of Longitudinal Association between Thiazolidinediones and Incidence and Progression of Diabetic Eye Disease: The ACCORD EYE Study.

artículo científico publicado en 2017

Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy

artículo científico publicado en 2010

Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes ⬇️

artículo científico publicado el 3 de marzo de 2011

Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes

artículo científico publicado en 2016

Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

artículo científico publicado en 2007

Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

artículo científico publicado en 2007

Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE).

artículo científico publicado en 2007

Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

artículo científico publicado en 2007

Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

artículo científico publicado en 2007

Systolic Blood Pressure Control Among Individuals With Type 2 Diabetes: A Comparative Effectiveness Analysis of Three Interventions

artículo científico publicado en 2015

The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods

artículo científico publicado en 2007

Lista de obras de

A Canadian Cohort Study of Cognitive Impairment and Related Dementias (ACCORD): Study Methods and Baseline Results

Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods

Cardiovascular Outcomes in Action to Control Cardiovascular Risk in Diabetes: Impact of Blood Pressure Level and Presence of Kidney Disease

Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes

Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.

Determinants of Weight Gain in the Action to Control Cardiovascular Risk in Diabetes Trial ⬇️

Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study

Effects of combination lipid therapy in type 2 diabetes mellitus

Effects of intensive blood-pressure control in type 2 diabetes mellitus

Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial

Effects of medical therapies on retinopathy progression in type 2 diabetes

Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design

Lack of Longitudinal Association between Thiazolidinediones and Incidence and Progression of Diabetic Eye Disease: The ACCORD EYE Study.

Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy

Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes ⬇️

Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes

Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE).

Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

Systolic Blood Pressure Control Among Individuals With Type 2 Diabetes: A Comparative Effectiveness Analysis of Three Interventions

The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods